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Abstract
Introduction: Traumatic injuries are amongst the leading causes of death worldwide, frequently as a result of
uncontrolled hemorrhage. Critical deficiencies in clotting factors have been noted in trauma-induced coagulopathy.
However, the exact underlying conditions that result in devastating coagulopathies remain unclear. The purpose of
this study was to elucidate these underlying deficiencies.
Methods: Blood samples were drawn from 45 severely injured trauma patients on their arrival at the
resuscitation room, and the activities of all soluble clotting factors and routine coagulation tests were assessed. The
Mann–Whitney-U-test was used to assess differences in coagulation activity between the patients and healthy
controls. Furthermore, Spearman’s rank correlation was used to analyze the blood work.
Results: After severe trauma the levels of serum fibrinogen and calcium were significantly reduced. Furthermore,
traumatized patients had a significantly increased International Normalized Ratio (INR) compared to healthy
controls. The median activities of all clotting factors were reduced after severe multiple trauma, with the exception
of factor VIII, which was increased. Statistically significant differences were observed for factors II (80 vs. 122 %,
P < 0.0001), V (76 vs. 123 %, P < 0.0001), VII (90 vs. 114 %, P = 0.002), VIII (200 vs. 108 %, P < 0.0001), and X (86 vs.
122 %, P < 0.0001). Spearman’s correlation indicated a significant negative correlation between INR on arrival with
fibrinogen and levels of factors II, V, and VII, whereas Partial Thromboplastin Time was significantly negatively
correlated with factor VIII (all P < 0.0001).
Conclusions: These findings suggest a general but rather moderate impairment of clotting factor activities
following severe multiple trauma. In the concept of a calculated coagulation therapy, this could demand for the
use of factor concentrates with higher ratios of clotting factors. Finally, the physiological importance of strongly
elevated factor VIII activity remains unclear, but a possible interference with ex vivo measurements of Partial
Thromboplastin Time has to be considered.
Keywords: Severe multiple trauma, Injury, Coagulation, Coagulopathy, Clotting factor, Coagulation factor,
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Introduction
Traumatic injuries account for more than 5 million
deaths annually and are among the leading causes of
death worldwide [1]. As many as 40 % of all mortalities
after severe multiple trauma are related to uncontrolled
hemorrhage [2, 3]. Several studies have reported a high
incidence of coagulopathy on admission to the emergency
department, and in this patient subgroup, mortality is
increased by up to 4-fold compared to patients without
coagulation abnormalities [4–8]. In fact, hemorrhage is
the most common preventable cause of death after severe
trauma and might be controlled by early aggressive ther-
apy, either by surgery or correction of coagulopathy [9].
Brohi et al. demonstrated that systemic hypoperfusion
in conjunction with tissue damage leads to widespread
activation of activated protein C and liberation of tissue
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plasminogen activator, potentially causing systemic antic-
oagulation and hyperfibrinolysis [10, 11]. Hypothermia
and acidemia further provoke the development of these
clotting disorders [12–14]. Additionally, dilution and con-
sumption of clotting factors may also significantly worsen
bleeding disorders in major trauma patients [7]. However,
little is known about the actual underlying clotting factor
activities after severe injury. Early studies have generally
focused on post-transfusional dysfunction at a later phase
of the disorder and have described only a small subset of
coagulation factors [15–18]. Recent studies from Rizoli et
al. and Cohen et al. investigated a broader panel of clot-
ting factors and indeed reported a significant correlation
between clotting factor deficiencies and transfusion re-
quirements [19, 20]. However, inclusion criteria aimed at
coagulopathic subgroups of patients, either by selecting
patients with highly reduced clotting factor activity
(<30 %) or those with demonstrated transfusion require-
ments (at least one unit of red blood cells). It therefore re-
mains unclear to what extent clotting factor deficiencies
may generally exist in multiple trauma patients irrespect-
ive of the further course.
For this study we investigated the potential derange-
ments of all soluble clotting factor activities early after
serious injury and discuss if these changes could be esti-
mated by standard coagulation tests.
Methods
Patients and normal donors
Adult patients were screened for enrollment if they were
admitted directly from the scene of an accident to the
trauma resuscitation room of our institution (Level 1
academic trauma center in Germany). Only severely in-
jured patients with an Injury Severity Score (ISS) of at
least 16 points were included. The study was performed
in accordance with the Declaration of Helsinki and ap-
proved by the relevant local ethics committee (reference
12-5120-BO). Participants provided written informed
consent. Pregnant women and patients known to have
congenital coagulopathies or who were on anticoagulant
medications were excluded. Ten healthy adult donors
served as the control group.
Blood samples
Directly after admission to the resuscitation room, blood
samples were drawn from the femoral artery. In addition
to routinely collected blood samples, an additional cit-
rate syringe was obtained to assess clotting factor activ-
ity. In healthy controls, blood was drawn from a cubital
vein. Immediately after collection, blood samples were
transferred to the hospital laboratory, and standard co-
agulation tests for International Normalized Ratio (INR),
Partial Thromboplastin Time (PTT), fibrinogen, and
calcium were performed. In addition, the activities of
clotting factors II, V, VII, VIII, IX, X, XI, XII, and XIII
were analyzed. Analysis was performed by comparing
samples to standard human plasma assays of clotting fac-
tors (SHP, Dade Behring Marburg GmbH, Marburg,
Germany). The results were expressed as a percentage of
standard activity. If immediate testing of clotting factor
activity was not possible, e.g., during off-duty hours,
specimens were cryo-stored at −70 °C until the final
analysis could be performed the following weekday.
Storage of frozen plasma samples is widely accepted
and has not been specifically shown to interfere with
clotting factor activity [21].
Statistical analysis
Demographic data is reported as mean and standard
deviation (SD) when applicable, while results are reported
as median values. Differences between demographic data
for the study groups were analyzed by t-test (age) or Fisher’s
exact test (gender). Differences in clotting factor activity
among patients and healthy controls were tested using the
Mann–Whitney-U-test. Differences in INR, PTT, serum
fibrinogen, and calcium among study groups were tested
in the same manner. In a second step, Spearman’s rank
correlation coefficient, rho (ρ), was calculated for trauma-
tized patients by analyzing the results of routine coagu-
lation tests as well as clinical data and clotting factor
activity assessments. The 95 % confidence interval (CI)
was computed by bootstrapping using a bias-corrected
and accelerated method based on 1000 bootstrap samples.
The correlation was considered negligible for absolute
values of ρ between 0.0 and 0.2, weak between 0.21 and
0.4, moderate between 0.41 and 0.7, strong between 0.71
and 0.9, and very strong between 0.91 and 1. A P value
smaller than 0.05 (2-tailed) was considered statistically sig-
nificant for all tests. Data analysis was strictly exploratory.
There was no correction for multiple testing. Data were
analyzed and graphs were produced using IBM® SPSS®
Statistics, Version 20 (Release 20.0.0).
All authors had access to primary clinical data.
Results
Demographic data
A total of 92 patients were enrolled in this study. A total
of 45 (49 %) fully met the inclusion criteria for analysis
Table 1 Demographic characteristics of the study population
Characteristics Patients (n = 45) Healthy controls (n = 10) P
Age; years ± SD 46 ± 19 40 ± 9 0.165
Gender; male (%) 36 (80 %) 7 (70 %) 0.673
ISS; points ± SD 31 ± 9 n/a n/a
Mechanism; blunt (%) 43 (96 %) n/a n/a
Mortality; n (%) 12 (27 %) n/a n/a
n/a not applicable
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and were included for testing against the healthy con-
trols. Of the enrolled patients, 23 (25 %) were excluded
from the study because the final evaluation revealed an
ISS below 16, 11 (12 %) were too young, and 6 (6 %)
were transferred from other hospitals. Three patients
were on anticoagulant medication, and three had no his-
tory of trauma. One patient died within minutes of their
admission. The baseline characteristics of the study
groups are summarized in Table 1. The mean age of
patients and healthy controls differed slightly but not
significantly (46 years in the patient group and 40 years
in the control group, P = 0.165). Overall, 80 % of patients
and 70 % of healthy controls were male (P = 0.673).
On average, patients were admitted to our hospital
66 ± 24 min after trauma. Further clinical data is given in
Table 2 for the patient group.
Routine tests of coagulation
Figure 1 shows the results of the routine coagulation
tests. On admission to the resuscitation room, the me-
dian levels of serum fibrinogen in trauma patients and
healthy controls were 230 mg/dL and 296 mg/dL, re-
spectively (P = 0.031). Furthermore, traumatized patients
had a significantly increased INR compared to the healthy
controls (1.10 vs. 0.96, P < 0.0001). By contrast, there was
no statistically significant difference in PTT between study
groups, although there was a tendency toward slightly
prolonged clotting time in controls (26.9 vs. 28.8 s, P =
0.116). Finally, serum calcium levels were significantly
reduced following multiple injury (2.11 [n = 44] vs. 2.30
millimole per liter, P < 0.0001).
Influence of trauma on clotting factor activity
The median activities of all clotting factors were reduced
after severe multiple trauma, with the exception of factor
VIII, which was clearly increased. The results reached
statistical significance for factors II (80 vs. 122 %, P <
0.0001), V (76 vs. 123 %, P < 0.0001), VII (90 vs. 114 %,
P = 0.002), VIII (200 vs. 108 %, P < 0.0001) and X (86 vs.
122 %, P < 0.0001). Although not statistically significant,
reductions in the median activity of factors IX (91 vs.
110 %, P = 0.141), XI (97 vs. 106 %, P = 0.270), XII
Table 2 Clinical data of the patient group
SBP (prehospital) SBP (admission) Lactate Base excess Temperature Hemoglobin Thrombocytes
124 (±37) mmHg 128 (±25) mmHg 2.4 (±2.0) mmol/l −3.1 (±4.4) mmol/l 35.7 (±1.1) °C 12.0 (±2.3) g/dl 202 (±55) / nl
Data reported as means (± standard deviation)
SBP systolic blood pressure, C celsius
Fig. 1 Results of routine coagulation tests. The results are presented as boxplots, bottom and top of the box indicate the 25th and 75th
percentile or interquartile range (IR). The horizontal bar within the box represents the median. Whiskers indicate spread (1.5 times IR). Outliers
(1.5 to 3 times IR) are indicated by circles, while extremes (greater than 3 times IR) are indicated by stars. The ordinate shows (A) INR ratio; (B) PTT
seconds; (C) fibrinogen mg/dL; (D) calcium millimole per liter. *, P < 0.05; #, P < 0.0001
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(89 vs. 99 %, P = 0.295) and XIII (84 [n = 44] vs. 102 %,
P = 0.09) were noted. Interestingly, factor VIII was the
only variable, including routine coagulation tests, whose
median was beyond the reference range of activity (70 –
150 % for this particular factor) set by the hospital
laboratory. The results are presented in Fig. 2.
Correlation of clotting factor activity and tests of
coagulation
For the patient group, Spearman’s Rank Correlation
Coefficient Rho (ρ) for routine coagulation tests and
clotting factor activity was calculated and is given in
Table 3 with associated confidence intervals (CI). A
strong (negative) correlation was observed between
INR on arrival with serum fibrinogen and factors II, V,
and VII (P < 0.0001). Correlation with the remaining
factors remained moderate (P < 0.0001–0.005), with the
exception of factor VIII. As shown in Fig. 3, PTT was
strongly negatively correlated with factor VIII (P < 0.0001).
Thus, PTT was the only variable with a relevant asso-
ciation with elevated factor VIII activity. PTT was also
moderately correlated with factors II, V, IX, and XII
(P < 0.0001). Levels of fibrinogen, also known as clot-
ting factor I, were moderately correlated with levels
of other factors, with the exception of factor XII (P <
0.0001–0.004), while calcium (factor IV) was barely asso-
ciated with factors II, V, IX, XI, and XII (P < 0.01).
Correlation of clotting factor activity and clinical data
No strong correlation between clotting factor activities
and the clinical data of the patients was found. Apart
from this, whereas the hemoglobin level at admission
showed a moderate correlation with all clotting factors
but factor VII (P < 0.0001–0.05), the remaining clinical
parameters correlated only sparsely and mostly not sig-
nificant with the various coagulation factors. Rho (ρ) for
correlation between clinical data and clotting factor
activity is given in Table 4 with associated CI.
Fig. 2 Changes in clotting factor activity after severe multiple trauma. The results are presented as boxplots, bottom and top of the box indicate
the 25th and 75th percentile or interquartile range (IR). The horizontal bar within the box represents the median. Whiskers indicate spread
(1.5 times IR). Outliers (1.5 to 3 times IR) are indicated by circles. The ordinate shows factor activities; (A) II, (B) V, (C) VII, (D) VIII, (E) IX, (F) X, (G) XI,
(H) XII, (I) XIII. **, P < 0.01; #, P < 0.0001
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Table 3 Correlation between coagulation tests and clotting factor activity in patients





















































































Data reported as Spearman’s Rank Correlation Coefficient, Rho (95 % CI)















The statistical analysis did not reveal statistically signifi-
cant differences in the baseline demographics of patients
and healthy controls. We assume that both groups were
comparable and changes in clotting factor activity after
severe trauma could be analyzed. A mean ISS of 31
points and an overall mortality of 27 % in patients also
implied relevant tissue traumatization. The predomin-
ance of blunt injury reflects the medical situation in
Germany and has been described previously [7]. How-
ever, this might have implications for the generalizability
of these findings to different patient populations as they
might differ in the incidence of penetrating trauma [22].
Because (isolated) penetrating trauma leads to uncon-
trolled hemorrhage rather than exorbitant tissue damage
and the pathophysiology of the observed changes may
depend on the trauma mechanism, divergent findings
could be obtainable. One aim of this study was to test
for clotting factor impairments as early as possible fol-
lowing trauma to exclude the influence of treatment. In
Germany, prehospital emergency physicians are involved
in patient care, and thus a potential bias related to indi-
vidualized patient care prior to admission cannot be fully
excluded. Hence, during the enrollment period no
general modification of routine prehospital trauma life
support was implemented in the study area. In-house
protocols for the initial care of polytraumatized patients
were also not modified. Furthermore, routine resuscitation
room algorithms in our institution provide for blood sam-
pling at the earliest possible time point. In a multidiscip-
linary strategy, blood is regularly drawn immediately after
patient arrival and usually occurs prior to the placement
of central venous lines. This strongly reduces the potential
interference of the different tests with relevant fluid resus-
citation. Laboratory analysis itself may be affected by the
variable degradation timeline of clotting factors. Again,
this cannot be fully excluded because several clotting
factors showed different half-lives [23]. However, because
blood specimens were immediately transported to the la-
boratory after withdrawal and, if necessary, promptly deep
frozen, this is unlikely.
As all primarily admitted patients irrespective of any
kind of predefined coagulopathic status were included
and results were compared with a reference group, this
study differs significantly from the existing ones [19, 20].
The findings of this study demonstrate that, with the
exception of factor VIII, clotting factor activities were
generally reduced in the early time period following
injury. Amongst others, serum levels of fibrinogen and
calcium were reduced significantly, a finding that has
been described by others [6, 24]. However, our results
do not support studies according to which fibrinogen
was the earliest and predominantly reduced factor after
traumatic blood loss [25, 26]. Consistent with the study
of Rizoli et al., we found the activity of factor V the most
deficient [19]. This predominance of a factor V deficiency
is a strong indicator of an activation of the protein c path-
way, which in turn seems to play a key role in the onset of
acute traumatic coagulopathy as proposed by Brohi et al.
[10, 11, 19]. Hence, the rather low correlation of clinical
parameters of tissue hypoperfusion (SBP, lactate, BE) with
clotting factor activities is somewhat contrary to the con-
cept of shock induced coagulopathy also supposed by
Brohi et al. [10, 11]. In general, the median activities did
not fall below the given reference range. This reflects the
rather minor rate of only twenty percent of coagulopathic
patients according to the inclusion criteria in the study of
Rizoli et al. As the authors stated, the threshold of 30 % of
activity is somewhat arbitrary and the clinical importance
of a less dramatic but simultaneous decline in the activity
of multiple clotting factors is unclear. Indeed, in our study
the median activities of clotting factors in the normal co-
hort frequently exceeded the “standard” activity of 100 %
and therefore the absolute reduction is even higher. Add-
itionally, those reference ranges were originally established
to assess single factor deficiencies and may not be appro-
priate for trauma patients. Therefore, the imminent reduc-
tion in almost all clotting factor activities should not be
underestimated as it might act as a potential contributor
to trauma-associated coagulopathy. In conclusion, these
findings should be considered when treating hemorrhagic
patients after severe multiple trauma, as higher ratios of
clotting factors might be needed to restore normal coagu-
lation function. Factor concentrates such as prothrombin
complex concentrate contain clotting factors in high
concentrations and might prove beneficial for treating the
deficiencies noted in our study. With respect to the
Fig. 3 Graphical expression of the correlation between PTT and
factor VIII. The dots represent pairs of PTT and factor VIII values. PTT,
seconds; factor VIII, activity. The linear regression line is given; linear
fit equation: factor VIII = −7 ∙ PTT + 404
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Table 4 Correlation between clinical data and clotting factor activity in patients



























































































































































Data reported as Spearman’s Rank Correlation Coefficient, Rho (95 % CI)














increased activity of factor VIII, our results are consistent
with the studies of Cohen and Jansen et al. [20, 27]. The
latter is based on a subgroup analysis from the work of
Rizoli et al. and reported a factor VIII activity level beyond
the upper limit of the range in 72 % of all patients. Indeed,
elevation of factor VIII activity seems to be the most ro-
bust effect of severe multiple trauma in terms of clotting
factor activities. A possible explanation is the known role
of factor VIII as an acute phase protein [28]. However, be-
cause our study design allowed for blood withdrawal quite
soon after injury, this might not fully explain the detected
levels of factor VIII at such an early time point. Further
explanations involve a direct liberation of factor VIII from
injured vessels and damaged tissues by unknown mecha-
nisms or, alternatively, active secretion. This might be rea-
sonable, as factor VIII is known to be produced by a wide
range of cells [29, 30]. However, the physiological rele-
vance of elevated factor VIII activity after severe trauma
remains unclear.
Prothrombin Time (PT) and PTT have major limita-
tions in the diagnosis of trauma induced coagulopathy
as they are time-consuming and lack the desirable sensi-
tivity at the critical time of admission. In addition, it is
unclear to what extent possible derangements of the
underlying coagulation system are reflected by PT and
PTT [31]. This has resulted in the emergence of visco-
elastic tests (rotational thromboelastometry [ROTEM]
or thromboelastography) as a point-of-care diagnostic
procedure for detecting acute coagulopathy after trauma
[32]. In experimental hypothermia and hemorrhage,
ROTEM showed superiority over PT and PTT in pre-
dicting coagulation disorders and mortality [33, 34]. In
this study, INR (reflecting PT) was significantly elevated
whereas differences in PTT were negligible. Indeed, an
abnormal PTT is known to occur more infrequently
than changes in PT [5]. The strongly elevated factor VIII
levels found in this study offer a possible explanation for
this phenomenon. As indicated by a strong negative cor-
relation, high plasma levels of factor VIII may “discredit”
the measurement of PTT, potentially leading to a re-
duced (quasi normal) clot formation time ex vivo. In this
context, PTT would be useless in an attempt to diagnose
traumatic coagulopathy. If viscoelastic tests are not
available, INR might be helpful as it highly correlated
with reduced levels of fibrinogen and the activities of
factors II, V, and VII. This finding is reasonable because
INR reflects PT, which was designed to test these factors
(formerly called the “extrinsic pathway”). Under these
circumstances, INR might be used despite its known
limitations to trigger coagulation therapy, e.g., by use of
fibrinogen concentrate and PCC. Nevertheless, future
studies are desirable to elucidate the potential of visco-
elastic tests to predict underlying clotting factor defi-
ciencies in trauma induced coagulopathy.
Conclusions
This prospective study compared clotting factor activ-
ities in patients during the early period following severe
multiple injury with a normal cohort. With the excep-
tion of factor VIII, activities of clotting factors are mod-
erately reduced. This should be considered in the initial
treatment after severe multiple trauma. In the concept
of a calculated coagulation therapy, this could demand
for the use of factor concentrates with higher ratios of
clotting factors. Finally, although the physiological im-
portance of elevated factor VIII activity after severe trauma
remains unclear, a possible interference with PTT meas-
urement ex vivo has to be considered.
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